Medifast Participates In ERSP Self-Regulatory Forum

New York, NY – July 31, 2005 – The Electronic Retailing Self-Regulation Program (ERSP), the electronic direct-response industry’s self-regulatory forum supervised by the National Advertising Review Council (NARC), announced that Medifast, marketers of The Medifast 980 Weight-Loss Plan, has voluntarily discontinued certain establishment claims , agreed to modify its testimonials, and agreed to add a disclaimer to clarify the Medifast program and results.

The marketer’s advertising was reviewed pursuant to ERSP’s ongoing monitoring program.

ERSP requested that Medifast, based in Owings Mills, Md., provide substantiation for both testimonial claims (i.e., “The first week I lost 9lbs…the 2nd week I lost 9lbs…at the end of the month I had lost 30 lbs.”) and establishment claims (i.e., “Medically proven to take the weight off fast and to keep it off”).

Medifast told ERSP that the company would voluntarily discontinue it claims that the Medifast-980
Program is “medically proven to take the weight off fast and to keep it off” and “medically proven for healthy weight loss in the shortest time possible.”

Medifast also said that it would eliminate, in future advertising, references to the amount of time it takes to lose certain amounts of weight.

Medifast supported its establishment claims with a study undertaken by the Johns Hopkins School of Medicine, entitled “Multicenter Evaluation of Health Benefits and Weigh loss on the Medifast Weight Management Program.”

ERSP concluded that the study, along with clear disclosure language that would indicate the claims are not applicable to all program participants, provided a reasonable basis for weight- loss testimonial claims.

Finally, ERSP determined that Medifast’s support for its “doctor recommended” claim was sufficient to support the claim, but should communicate in future advertising that the doctors’ recommendations pertains to Medifast programs in general and not the Medifast-980 program.

In response to ERSP’s decision, Medifast responded that the company is “gratified that … the … study independently supported the weight loss claims made in our consumer testimonials…[and]also appreciate
…that Medifast’s claim that over 15,000 doctors have recommended Medifast is accurate.”

“We concur with [ERSP’s} recommendations and will implement them. Medifast has been helping people lose weight for over 25 years, and we value our excellent reputation within the medical community and with consumers.”

 

Subscribe to the Ad Law Insights or Privacy Initiatives newsletters for an exclusive monthly analysis and insider perspectives on the latest trends and case decisions in advertising law and data privacy.

 

 

 

 

Latest Decisions

Decision

National Advertising Division Recommends Blueprint Test Preparation Discontinue Certain MCAT Score Improvement Claims

New York, NY – April 22, 2024 – The National Advertising Division recommended Blueprint Test Preparation discontinue certain express and implied claims made in connection with its four MCAT preparation courses, including claims that Blueprint students raise their MCAT scores by 15 or 13 points on average.

Read the Decision Summary
Decision

National Advertising Division Recommends The Princeton Review Discontinue Point Increase Claims for MCAT Test Preparation Services

New York, NY – April 18, 2024 – In a Fast-Track SWIFT challenge, the National Advertising Division recommended that The Princeton Review (TPR) discontinue claims that its students “Score a 515+ on the MCAT or add 15 points depending on your starting score. Guaranteed or your money back.”

Read the Decision Summary
Decision

Direct Selling Self-Regulatory Council Recommends Trades of Hope Discontinue Salesforce Member Earnings Claims

McLean, VA – April 17, 2024 – The Direct Selling Self-Regulatory Council (DSSRC) recommended that Trades of Hope discontinue certain earnings claims made by salesforce members on Facebook and YouTube. 

Read the Decision Summary
Decision

National Advertising Division Recommends Lily of the Desert Nutraceuticals Discontinue “100% Pure Avocado Oil” Claim for Tropical Plantation Avocado Oil

New York, NY – April 15, 2024 – The National Advertising Division recommended that Lily of the Desert Nutraceuticals discontinue the claim “100% Pure Avocado Oil” for its Tropical Plantation Avocado Oil and avoid conveying the unsupported message that the product is 100% pure avocado...

Read the Decision Summary